Pfizer (PFE) stock is in focus as Xtandi, marketed with Astellas (ALPMF), and cancer drug Talzenna succeed in a Phase 3 trial for prostate cancer. Read more here.
Abstract: Prostate cancer stands as the second most frequent form of cancer found in men. Early and accurate disease diagnosis is crucial, particularly during the initial stages when prostate-specific ...
Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
The Northern Territory Government’s critical minerals guide has added bismuth, iron ore, lead, silver and uranium, and now features gold for the first time as the Territory looks to strengthen its ...
Early prostate specific antigen response and overall survival in metastatic hormone sensitive prostate cancer: Real-world data on age, body mass index, and treatment. Treatment outcomes of patients ...
Abstract: This work describes the development of a novel prostate cancer treatment using docetaxel-encapsulated gold nanoparticles (AuNPs) for drug delivery applications. The functionalization of gold ...
Genesis Minerals is set to unlock its one million-ounce Tower Hill deposit, appointing GR Engineering Services to build a new 3.5–4 million tonne per annum (Mtpa) gold processing plant at Leonora, ...
John (Eddie) La Marca receives funding from Cancer Council Victoria. He is affiliated with the Olivia Newton-John Cancer Research Institute and the Walter and Eliza Hall Institute of Medical Research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results